NUR550 Translation Research and Population Health Management Week 6 Assignment
Grand Canyon University NUR550 Translation Research and Population Health Management Week 6 Assignment-Step-By-Step Guide
This guide will demonstrate how to complete the Grand Canyon University NUR550 Translation Research and Population Health Management Week 6 Assignment assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for NUR550 Translation Research and Population Health Management Week 6 Assignment
Whether one passes or fails an academic assignment such as the Grand Canyon University NUR550 Translation Research and Population Health Management Week 6 Assignment depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for NUR550 Translation Research and Population Health Management Week 6 Assignment
The introduction for the Grand Canyon University NUR550 Translation Research and Population Health Management Week 6 Assignmentis where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
How to Write the Body for NUR550 Translation Research and Population Health Management Week 6 Assignment
After the introduction, move into the main part of the NUR550 Translation Research and Population Health Management Week 6 Assignment assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for NUR550 Translation Research and Population Health Management Week 6 Assignment
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for NUR550 Translation Research and Population Health Management Week 6 Assignment
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NUR550 Translation Research and Population Health Management Week 6 Assignment assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
Week 6 Assignment
Benchmark – Part B: Literature Review
In Part A, you described the population and quality initiative related to your PICOT (Population/Problem, Intervention, Comparison, Outcome, and Time to achieve the outcome) statement. In this assignment, you will formalize your PICOT and research process.
Use the GCU Library to perform a search for peer-reviewed research articles. Find five peer-reviewed primary source translational research articles.
In a paper of 1,250-1,500 words, synthesize the research into a literature review. The literature review should provide an overview for the reader that illustrates the research related to your particular PICOT. Include the following:
Introduction: Describe the clinical issue or problem you are addressing.
Methods: Describe the criteria you used in choosing your articles
Synthesize the Literature: Part A: Discuss the main components of each article (subjects, methods, key findings) and provide rationale for how this supports your PICOT; Part B: Compare and contrast the articles: Discuss limitations, controversies, and similarities/differences of the studies.
Areas of Further Study: Analyze the evidence presented in your articles to identify what is known, unknown, and requires further study.
You are required to cite five to 10 sources to complete this assignment. Sources must be published within the last 5 years and appropriate for the assignment criteria and nursing content.
Prepare this assignment according to the guidelines found in the APA Style Guide, located in the Student Success Center. An abstract is not required.
This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
You are required to submit this assignment to LopesWrite. Please refer to the directions in the Student Success Center.
Sample Answer for NUR550 Translation Research and Population Health Management Week 6 Assignment
Description of the Clinical Issue
Major depressive disorder is recognized as a highly prevalent disorder with serious health problems to the patients, their families and the community as a whole. According to statistics, the lifetime prevalence of the disease in the US is 16% while it affects above 30 million Europeans (Gartlehner et al., 2017). The statistics imply that more than 16 million people in America aged above 18 years are affected by the disease on an annual basis (Dunlop et al., 2019). The disorder is mainly characterized by symptoms that include low self-confidence, low vigor, aversion of activities without any reason, and low mood. Functional impairment occurs due to the influence of a wide range of symptoms that include suicidality, impaired concentration, sleep disturbance, and anhedonia (Dunlop et al., 2019). The risk of its recurrence is significantly high, which increases the disease burden as well as the need for interventions that aim at promoting the mental and physical health of the patients. Sadly, the severity of the symptoms and the effects it has on one’s health increases with every subsequent recurrence. For instance, relapses result in significant mental, social, physical, and financial costs to the family, patient, and the society as a whole (Zhang et al., 2018).
Statistics have shown that the prevalence rate of major depressive disorder among African-American population is lower than that of Caucasians in the state. However, the risks of complications among them are significantly high despite the prevalence among them being low. The difference is largely attributed to factors such as their poor utilization of the available healthcare services, low access to the existing mental health services, and access to mental health services that are of low quality. There is also the fact that issues such as norms and cultural values influence the utilization of mental health services among African-Americans. It is expected that a society’s negative perception towards mental health issues due to the influence of cultural beliefs and practice will reduce the utilization of the available mental health services (Sohail et al., 2014).
The use of antidepressants is largely known as the gold approach to managing major depressive disorder. Research has consistently shown that medications such as selective serotonin reuptake inhibitors are effective in treating the symptoms and relapse associated with the disorder (Zhang et al., 2018). There is also the increasing use of non-pharmacological interventions in the management of major depressive disorder. The preference of non-pharmacological methods arises from the health effects that are attributed to antidepressants therapies. Statistics have shown that up to 63% of the patients on antidepressant therapy experience adverse outcomes of the medications, which lead to 7-15% of them discontinuing the treatment (Gartlehner et al., 2017). There is limited evidence on whether a combined use of pharmacotherapy and non-pharmacotherapy will reduce the health impacts of major depressive disorder or not. Therefore, this proposed research will explore it, with the guidance of the following PICOT question:
In African-American patients with major depressive disorder, will the use of combined intervention involving cognitive behavioral therapy and antidepressants reduce severity of complications when compared to the use of antidepressants alone within 12 months?
Methods
A search of the relevant articles was done on various databases such as EMBASE, MEDLINE, Cochrane, CINAHL, Google Scholar, and HAPI. The search words that were used included major depressive disorder, pharmacological management, non-pharmacological management, and combined use of pharmacological and non-pharmacological methods in the management of major depressive disorder. Relevant articles were chosen based on specific criteria. One of them was articles that explored the use of pharmacological interventions and non-pharmacological intervention in management of major depressive disorder. The other criterion was age of the articles. The selected articles were published within the last five years. In the end, the articles by Dunlop et al. (2019) Kuyken et al. (2015), Bockting et al. (2018), Boschloo et al. (2019) and Dunlop et al. (2019b) were chosen.
Literature Synthesis
Part A: Components of Each Article
The article by Dunlop et al., (2019b) examined the benefits of adding cognitive behavioral therapy or antidepressants in treating non-remitting depression. It used adults who had been treated with major depressive disorder who were randomly assigned to treatment (duloxetine, escitalopram or CBT monotherapy) for 12 weeks. Those who did not show any relapse were recruited into 12 weeks of combined treatment. The findings showed that adding antidepressant sequentially does not have any significant impact when compared to combined therapy. This article underpins the proposed research as it illuminates light into the efficacy of the combined therapy versus monotherapy.
The research by Kuyken et al. (2015) was conducted to compare the cost-effectiveness and effectiveness of combined antidepressants and mindfulness-based cognitive therapy in preventing relapse in patients with major depressive disorder. The study used 424 patients with the disorder where they were assigned to either the treatment group or the control. The outcomes showed that combined therapy is superior to monotherapy in preventing relapse in individuals with the disorder. The use of either treatment was also found to have enduring positive effect in relation to depressive symptoms, quality of life, and relapse recurrence. This article will be used to show whether combined therapy is superior to monotherapy, and recommendations that should be considered.
The research by Bockting et al. (2018) examined the effectiveness of cognitive therapy when tapering antidepressants when compared to maintenance antidepressant therapy versus their combination in preventing relapse of depressive symptoms in patients with major depression. The research was a randomized controlled trial where three parallel groups consisting of 289 patients were randomly assigned to the treatment and control. The study outcomes showed that addition of preventive cognitive therapy is superior to maintenance antidepressant in facilitating recovery. Therefore, it should be offered to patients who are recovering from a major depressive disorder. This article will add more information on the efficacy of combined therapy versus monotherapy.
The research by Boschloo et al. (2019) compared the symptom efficacy of cognitive behavioral therapy and antidepressant medications in treating depression. The research was a meta-analysis where randomized clinical trials were examined to come up with conclusions on the topic. The results showed that antidepressant medications are superior over cognitive behavioral therapy in terms of precision psychiatry. This research will inform the proposal by giving insights into the efficacy of the treatments.
The research by Dunlop et al. (2019) examined the effect of either antidepressant medications or cognitive behavioral therapy in treating major depressive disorder. The study used 350 adults with the disorder who were randomized to either of the two treatments. The results showed that antidepressant therapy is effective than CBT in reducing suicidal ideation even in patients known to have minimal benefits with the use of antidepressant medications. This article recommends the need for a research comparing the effectiveness of combined therapy versus monotherapy.
Part B: Comparing and Contrasting Articles
The researches by Dunlop et al. (2019b) and Dunlop et al. (2019) are associated with strengths that include randomization of the study participants and rigor in their methodologies. However, their sample sizes are small to give conclusive recommendations for evidence-based practice. The research Kuyken et al. (2015) and Bockting et al. (2018) have similar strengths to those by Dunlop et al. (2019b) and Dunlop et al. (2019). Unlike the above, the research by Kuyken et al. (2015) and Bockting et al. (2018) used larger sample sizes, which make their findings highly generalizable to the wider population of patients suffering from the disorder. While the study by Boschloo et al. (2019) has explicitly explored previous studies in the topic in their meta-analysis, they have the weakness of not using study participants to develop their conclusions. Some of the reviewed studies had methodological weaknesses, which reduce the reliability of their findings.
Areas of Further Study
Combined therapy appears to have more health benefits to patients suffering from major depressive disorder when compared to monotherapy (Dunlop et al., 2019b; Kuyken et al., 2015; Bockting et al., 2018; Dunlop et al., 2019). However, there is significant knowledge gap in evidence on the effectiveness of these interventions in patients from African-American ethnicities. The fact that a significant proportion of African-American patients develop complications of major depressive disorder also increases the need for a research on the diverse treatment approaches to improve their health outcomes. The selected studies for this research have predominant weaknesses such as small sample sizes and meta-analyses of previous studies. As a result, it increases the need for a research on a specific ethnicity that uses a large sample size to inform practice. Consequently, there is an increased need for the proposed intervention, as it will aid in adding knowledge on the topic and promote evidence-based practice in the provision of mental health services to the vulnerable populations.
References
Bockting, C. L., Klein, N. S., Elgersma, H. J., van Rijsbergen, G. D., Slofstra, C., Ormel, J., … & Schene, A. H. (2018). Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial. The Lancet Psychiatry, 5(5), 401-410.
Boschloo, L., Bekhuis, E., Weitz, E. S., Reijnders, M., DeRubeis, R. J., Dimidjian, S., … & Jarrett, R. B. (2019). The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis. World Psychiatry, 18(2), 183-191.
Dunlop, B. W., Polychroniou, P. E., Rakofsky, J. J., Nemeroff, C. B., Craighead, W. E., & Mayberg, H. S. (2019). Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder. Psychological medicine, 49(11), 1869-1878.
Dunlop, B. W., LoParo, D., Kinkead, B., Mletzko-Crowe, T., Cole, S. P., Nemeroff, C. B., … & Craighead, W. E. (2019b). Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. American Journal of Psychiatry, 176(4), 275-286.
Gartlehner, G., Wagner, G., Matyas, N., Titscher, V., Greimel, J., Lux, L., … & Lohr, K. N. (2017). Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ open, 7(6), e014912.
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., … & Causley, A. (2015). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. The Lancet, 386(9988), 63-73.
Sohail, Z., Bailey, R. K., & Richie, W. D. (2014). Misconceptions of depression in African Americans. Frontiers in Psychiatry, 5, 65.
Zhang, Z., Zhang, L., Zhang, G., Jin, J., & Zheng, Z. (2018). The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis. BMC psychiatry, 18(1), 50.